Posterior reversible encephalopathy syndrome in a patient with ANCA-associated vasculitis.
Posterior reversible encephalopathy syndrome (PRES) is a clinical syndrome that manifests with the onset of headache, confusion or decreased level of consciousness, visual changes, and seizures in conjunction with the typical neuroimaging features of posterior cerebral white matter changes, which are usually reversible. This syndrome has been associated with hypertension, eclampsia, renal insufficiency, immunosuppressive drugs, and connective-tissue diseases. To our knowledge, only four cases of PRES associated with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis have been reported in the literature. Here, we present a patient with ANCA-associated vasculitis complicated by PRES.
Fuentes
Alexandra Gonzalez
AG
Section of Immunology, Allergy and Rheumatology, Baylor College of Medicine, Houston, TX, USA. alex17go@yahoo.com
Komarla
Ashwini
A
Gomez
John I
JI
D000368:Aged; D056648:Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D000927:Anticonvulsants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001706:Biopsy; D001921:Brain / Q000473:pathology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007668:Kidney / Q000473:pathology; D008279:Magnetic Resonance Imaging; D054038:Posterior Leukoencephalopathy Syndrome / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D006435:Renal Dialysis; D016896:Treatment Outcome
D000927:Anticonvulsants; D000959:Antihypertensive Agents; D007166:Immunosuppressive Agents